These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9265405)

  • 41. [Clinical evaluation of chemiluminescence immunoassay PSA (ACS-PSA) for detection of prostate cancer].
    Adachi T; Moriya K; Esaki K
    Hinyokika Kiyo; 1998 Jul; 44(7):469-76. PubMed ID: 9752600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
    Djavan B; Remzi M; Zlotta AR; Seitz C; Wolfram R; Hruby S; Bursa B; Schulman CC; Marberger M
    Tech Urol; 1999 Jun; 5(2):71-6. PubMed ID: 10458658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate cancer detection by prostate-specific antigen-related parameters.
    Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
    Bissoli E; Fandella A; La Torre E; Faggiano L; Anselmo G; Frasson F
    Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml.
    Lodeta B; Benko G; Car S; Filipan Z; Stajcar D; Dujmović T
    Acta Clin Croat; 2009 Jun; 48(2):153-5. PubMed ID: 19928413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer.
    Mochtar CA; Rahardjo D; Umbas R
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():514-22. PubMed ID: 10895203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?
    Handel LN; Agarwal S; Schiff SF; Kelty PJ; Cohen SI
    Urology; 2006 Dec; 68(6):1220-3. PubMed ID: 17141826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
    Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
    BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
    Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
    Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The diagnostic effectiveness of repeat echo-guided transrectal biopsy as a function of the clinical and anatomicopathological findings].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A; García Burgos J
    Actas Urol Esp; 1999 May; 23(5):394-9. PubMed ID: 10427812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis of prostate cancer with PSA < or =4.0 microg/L].
    Liu X; Tang J; Fei X; Li QY
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):234-8. PubMed ID: 24738460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
    Xiao LP; Bi XJ; Li YN; Chen XQ; Zhang XF; Yu XP; Liu G; Yang MC; Song Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Multiple prostatic biopsies in the "gray zone" of the specific prostatic antigen].
    Drudi FM; Ricci P; Iannicelli E; Di Nardo R; Novelli L; Laghi A; Perugia G; Passariello R
    Radiol Med; 2000; 99(1-2):81-5. PubMed ID: 10803192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of prostate specific antigen (PSA) adjusted to transition zone in prostatic cancer detection].
    Jara Rascón J; Subirá Rios D; Lledó Garcia E; Martínez Salamanca JI; Moncada Iribarren I; Hernández Fernández C
    Actas Urol Esp; 2005 May; 29(5):485-92. PubMed ID: 16013794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Yield of transrectal ultrasonography in the diagnosis of prostatic cancer in symptomatic patients with normal rectal digital test].
    Herranz Amo F; Verdu Tartajo F; Diez Cordero JM; Sánchez Carreras F; Lledo García E; Bueno Chomon G; Leal Hernández F
    Actas Urol Esp; 1997 Jun; 21(6):565-71. PubMed ID: 9412190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.